Follow The Filings

Friday, October 23, 2026

2026 Q3 13Fs: 7 of 137 filed, due 16 Nov

13F holdings, earnings, insider and Congress trades, as filed with the SEC

13F holdings

Companies

Congress

COAGHemab Therapeutics Holdings Inc.

Q2 2026 13F holders among managers we track Latest ownership dossier

Ticker: COAG
Type: Equity
Class: COM SHS
Total reported value (long equity)

Manager	Report date	Value	Shares